Diagnosis, treatment and prevention of severe acute respiratory syndrome coronavirus 2 infection in children: experts′ consensus statement (Fourth Edition)
- VernacularTitle:儿童新型冠状病毒感染诊断、治疗和预防专家共识(第四版)
- Author:
Rongmeng JIANG
1
;
Zhengde XIE
;
Yi JIANG
;
Xiaoxia LU
;
Runming JIN
;
Yuejie ZHENG
;
Yunxiao SHANG
;
Baoping XU
;
Zhisheng LIU
;
Gen LU
;
Jikui DENG
;
Guanghua LIU
;
Xiaochuan WANG
;
Jianshe WANG
;
Luzhao FENG
;
Wei LIU
;
Yi ZHENG
;
Sainan SHU
;
Min LU
;
Wanjun LUO
;
Miao LIU
;
Yuxia CUI
;
Leping YE
;
Adong SHEN
;
Gang LIU
;
Liwei GAO
;
Lijuan XIONG
;
Yan BAI
;
Likai LIN
;
Zhuang WEI
;
Fengxia XUE
;
Tianyou WANG
;
Dongchi ZHAO
;
Zhengyan ZHAO
;
Jianbo SHAO
;
Kwok-keung Daniel NG
;
Wing-kin Gary WONG
;
Xingwang LI
;
Yonghong YANG
;
Kunling SHEN
Author Information
- Keywords: Severe acute respiratory syndrome coronavirus 2 infection; Child; Diagnosis; Treatment; Prevention; Consensus
- From: Chinese Journal of Applied Clinical Pediatrics 2022;37(14):1053-1065
- CountryChina
- Language:Chinese
- Abstract: Since December 2019, severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infections have raged globally for more than 2 years.China has always adopted scientific and effective prevention and control measures to achieved some success.However, with the continuous variation of SARS-CoV-2 cases and imported cases from abroad, the prevention and control work has become more difficult and complex.With the variation of the mutant strain, the number of cases in children changed, and some new special symptoms and complications were found, which proposed a new topic for the prevention and treatment of SARS-CoV-2 infection in children in China.Based on the third edition, the present consensus according to the characteristics of the new strain, expounded the etiology, pathology, pathogenesis, and according to the clinical characteristics and experience of children′s cases, and puts forward recommendations on the diagnostic criteria, laboratory examination, treatment, prevention and control of children′s cases for providing reference for further guidance of effective prevention and treatment of SARS-CoV-2 infection in children in China.
